首页 News 正文

On June 10th, Lilly's Alzheimer's disease (AD) drug Donanemab was unanimously approved by the FDA's Advisory Committee on Peripheral and Central Nervous System Drugs (PCNS).
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

楚一帆 注册会员
  • 粉丝

    0

  • 关注

    0

  • 主题

    38